ESNATS - Embryonic Stem cell-based Novel Alternative Testing Strategies


pulled from site's meta description

The EC-funded FP7 collaborative research project ESNATS (Embryonic Stem cell-based Novel Alternative Testing Strategies) aims at developing a novel toxicity test platform based on embryonic stem cells (ESCs), in particular human ESC (hESCs) to accelerate drug development, reduce related R&D costs and propose an alternative to animal tests. To reach these goals, ESNATS will develop a battery of toxicity tests using hESC lines subjected to standardised culture and differentiation protocols. Tests cover reproductive toxicity, neurotoxicity, metabolism and toxicokinetics and will be integrated into an

Domain Resolution

This domain resolves to the following IP addresses:

This is an automatically generated AboutUs page for Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.

Retrieved from ""